Marc K. Hellerstein
Department of Nutritional Sciences
University of California at Berkeley
Berkeley
CA 94720
USA
Name/email consistency: high
- A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control: advantages of pathway-based discovery. Hellerstein, M.K. Metab. Eng. (2008)
- Exploiting complexity and the robustness of network architecture for drug discovery. Hellerstein, M.K. J. Pharmacol. Exp. Ther. (2008)
- Stable isotope-mass spectrometric measurements of molecular fluxes in vivo: emerging applications in drug development. Hellerstein, M.K., Murphy, E. Curr. Opin. Mol. Ther. (2004)
- Measurement of mitochondrial DNA synthesis in vivo using a stable isotope-mass spectrometric technique. Collins, M.L., Eng, S., Hoh, R., Hellerstein, M.K. J. Appl. Physiol. (2003)
- In vivo measurement of fluxes through metabolic pathways: the missing link in functional genomics and pharmaceutical research. Hellerstein, M.K. Annu. Rev. Nutr. (2003)
- Turnover of adipose components and mitochondrial DNA in humans: kinetic biomarkers for human immunodeficiency virus-associated lipodystrophy and mitochondrial toxicity?. Hellerstein, M.K. Clin. Infect. Dis. (2003)
- Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. Hellerstein, M.K., Hoh, R.A., Hanley, M.B., Cesar, D., Lee, D., Neese, R.A., McCune, J.M. J. Clin. Invest. (2003)
- Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Hellerstein, M.K. Curr. Opin. Lipidol. (2002)
- Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Hellerstein, M.K., Neese, R.A. Am. J. Physiol. (1999)
- Measurement of T-cell kinetics: recent methodologic advances. Hellerstein, M.K. Immunol. Today (1999)